Genesis Therapeutics · Strategic Equity Investment
AI drug-discovery company building generative and predictive models to design small-molecule
Amount
$40M
Round
Strategic Equity Investment
Valuation
—
Announced
May 2026
Investors
Lead investor
IncyteNotes
funding refresh
Other Genesis Therapeutics rounds
| Date | Round | Amount | |
|---|---|---|---|
| — | Series B | $200M | Details → |